Summary

Industry

Health and BioTech

Year of Investment

2024

Website

https://relume.dk/

Last round

Relume

AI-designed drugs to reprogram the immune system for rare eye cancers.

Company description

AI-designed drugs to reprogram the immune system for rare eye cancers.

Fundraising blurb

Company highlights

Summary

Industry

Health and BioTech

Year of Investment

2024

Website

https://relume.dk/

Last round

No

founders

Huram Konjen

Featured video

More companies

No items found.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.